The market seems to be falling heavily out of love with the AI stocks, and for good reason: CapEx is rising at a staggering rate, especially among the Mag Seven AI darlings, all while the question ...

Researchers at the Johns Hopkins Kimmel Cancer Center report that an artificial intelligence (AI)-based liquid biopsy test ...

AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.

As a range of new artificial intelligence startups over the past two years have launched their own search engines, such as ...

Company launches initiative to become a dedicated AI infrastructure partner for the biotechnology industry - to deploy secure, on-premises AI systems directly within client environments where propriet ...

Comprising 1,016 Nvidia Blackwell Ultra GPUs, the SuperPOD offers more than 9,000 petaflops of AI performance and will be used to train biomedical foundation and frontier models, reducing drug ...

The pharmaceutical industry is racing to turn its data into scientific intelligence with AI. Now, it’s possible to connect your data and tool ecosystem. There is a gold rush happening in ...

A Cardiff-based artificial intelligence-driven Techbio company has secured a joint equity investment to accelerate its drug discovery work and create jobs.

Experts say the emerging tech can dramatically accelerate advances in drug discovery, diagnostics and precision medicine.

Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on private pharmaceutical infrastructure ...

The session Next-Generation Drug Development Enabled by Automation, Digitalization, and AI/ML is scheduled to take place at Pittcon 2026 in San Antonio, TX, on Monday, March 9, from 8:30 am–10:40 am ...

SANTA CLARA, CA, UNITED STATES, March 3, 2026 / EINPresswire.com / — OmicInsight, a pioneer in spatial biology, today announced a strategic leadership realignment to accelerate its AI Transformation ...